Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Novo Nordisk, Starbucks shares slumping: Trending Tickers
Wealth host Brad Smith discusses some of Wednesday's trending stocks. Novo Nordisk (NVO) stock is sinking after European drugmaker Roche (ROG.SW) reached a deal with Zealand Pharma (ZEAL.CO) to ...
Branding Best Practices: Tips For Telehealth Weight Loss Companies
In an increasingly competitive telehealth weight loss market, thoughtful and transparent branding is critical.
New York Utility Company May Raise Bills to Cover Employees' Ozempic
Customers can expect a rate hike up to 14 percent as employee welfare costs surge related to Ozempic and drugs like it.
The Courier-Mail21h
Qld kids in ‘deadly’ schoolyard Ozempic diet clubs
Secret schoolyard ozempic clubs are forming. “In reality, these kinds of weight-loss medications can be very dangerous, with some people reporting alarming physical side effects which can lead ...
Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall.
Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement. Zealand Pharma's ...